Indoco gets USFDA approval for Olanzapine tablets
Olanzapine is indicated for the treatment of schizophrenia and bipolar disorder
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Schizophrenia
New insight into genetic schizophrenia risk
For the first time, research reported by the team in the journal Cell Reports, has shown that the 16p11.2 duplication impacts on a…
Zydus Cadila to market anti-psychotic drug
The drug is used to treat schizophrenia and the manic symptoms of bipolar disorder, has received US FDA approval
Sun Pharma settles trademark litigation with Psyco Remedies
Post reaching the settlement, a joint request for compromise was filed by both companies before the Madras High Court, where they…
US FDA nod for generics of Abilify
To market generic aripiprazole in multiple strengths and dosage forms to treat mental disorders
3 Indian cos receive US FDA nod for 1st generic Abilify to treat mental illnesses
Alembic Pharmaceuticals, Hetero Labs, Teva Pharmaceuticals and Torrent Pharmaceuticals have received FDA approval to market…
Suven Life secures five product patents
The granted claims of the patents include the class of selective 5-HT compounds and are being developed as therapeutic agents
Suven initiates MAD studies in phase 1 clinical trial for investigational compound SUVN-G3031
SUVN-G3031 is a potent, selective, brain penetrant and orally active Histamine H3 inverse agonist being developed for the…